Levin Capital Strategies L.P. cut its stake in Acadia Healthcare Company Inc (NASDAQ:ACHC) by 6.0% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 15,000 shares of the company’s stock after selling 960 shares during the period. Levin Capital Strategies L.P.’s holdings in Acadia Healthcare were worth $386,000 at the end of the most recent reporting period.
Other institutional investors also recently modified their holdings of the company. Cumberland Advisors Inc. purchased a new position in Acadia Healthcare in the fourth quarter valued at about $593,000. State Treasurer State of Michigan increased its stake in shares of Acadia Healthcare by 7.9% during the 3rd quarter. State Treasurer State of Michigan now owns 32,600 shares of the company’s stock worth $1,148,000 after purchasing an additional 2,400 shares in the last quarter. American International Group Inc. increased its stake in shares of Acadia Healthcare by 8.6% during the 3rd quarter. American International Group Inc. now owns 179,412 shares of the company’s stock worth $6,315,000 after purchasing an additional 14,175 shares in the last quarter. Strs Ohio purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth approximately $308,000. Finally, Fort Washington Investment Advisors Inc. OH purchased a new position in shares of Acadia Healthcare during the 3rd quarter worth approximately $20,242,000.
A number of brokerages have recently weighed in on ACHC. Zacks Investment Research raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Monday, November 12th. BidaskClub raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Wednesday, October 31st. Cantor Fitzgerald reissued a “hold” rating and set a $39.00 price objective on shares of Acadia Healthcare in a research note on Thursday, October 18th. Mizuho set a $37.00 price objective on shares of Acadia Healthcare and gave the stock a “hold” rating in a research note on Thursday, October 18th. Finally, ValuEngine raised shares of Acadia Healthcare from a “sell” rating to a “hold” rating in a research note on Friday, October 26th. Two analysts have rated the stock with a sell rating, nine have issued a hold rating and three have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $40.36.
About Acadia Healthcare
Acadia Healthcare Company, Inc develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities. The company operates acute inpatient psychiatric facilities, which offer evaluation and crisis stabilization of patients with severe psychiatric diagnoses; specialty treatment facilities, including residential recovery facilities, eating disorder facilities, and comprehensive treatment centers that provide continuum care for adults with addictive disorders and co-occurring mental disorders; and residential treatment centers, which treat patients with behavioral disorders in a non-hospital setting, including outdoor programs.
Read More: How Do Front-End Loads Impact an Investment?
Receive News & Ratings for Acadia Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Acadia Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.